Article ; Online: Epidemiology of community-acquired pneumonia caused by S treptococcus pneumoniae in older adults: a narrative review.
Current opinion in infectious diseases
2024 Volume 37, Issue 2, Page(s) 144–153
Abstract: Purpose of review: This review covers updated perspectives on different aspects of pneumococcal community-acquired pneumonia (pCAP), including the epidemiology, clinical presentation, risk factors, antibiotic treatment, and existing preventive ... ...
Abstract | Purpose of review: This review covers updated perspectives on different aspects of pneumococcal community-acquired pneumonia (pCAP), including the epidemiology, clinical presentation, risk factors, antibiotic treatment, and existing preventive strategies in older adults. Recent findings: pCAP remains the most prevalent condition among lower respiratory tract infections in the older adults according to Global Burden of Diseases 2019. Older adults can display atypical symptoms such as confusion, general clinical deterioration, new onset of and exacerbation of underlying illness that might trigger clinical suspicion of pCAP. Older adults with pCAP often experience increased disease severity and a higher risk of pulmonary complications compared with younger individuals, owing to age-related changes in immunity and a higher prevalence of comorbidities. Vaccination stands fundamental for prevention, emphasizing the need for effective immunization strategies, specifically tailored for older adults. There is a pressing need to reinforce efforts aimed at boosting pneumococcal vaccination rates. Summary: Despite a high morbidity and mortality, the burden of pCAP, in particular hospital admission and occurrence of invasive infections, among the elderly population is not sufficiently documented. This review findings emphasize the substantial burden of pCAP in this vulnerable population, driven by factors such as advancing age and underlying comorbidities. The emergence of antibiotic-resistant pneumococcal strains further complicates treatment decisions and highlights the importance of tailored approaches for managing pCAP in older adults. |
---|---|
MeSH term(s) | Humans ; Aged ; Pneumonia, Pneumococcal/epidemiology ; Pneumonia, Pneumococcal/prevention & control ; Streptococcus pneumoniae ; Respiratory Tract Infections/epidemiology ; Hospitalization ; Comorbidity ; Community-Acquired Infections/epidemiology ; Community-Acquired Infections/prevention & control ; Pneumococcal Vaccines ; Pneumococcal Infections/epidemiology ; Pneumococcal Infections/prevention & control |
Chemical Substances | Pneumococcal Vaccines |
Language | English |
Publishing date | 2024-02-05 |
Publishing country | United States |
Document type | Review ; Journal Article |
ZDB-ID | 645085-4 |
ISSN | 1473-6527 ; 1535-3877 ; 0951-7375 ; 1355-834X |
ISSN (online) | 1473-6527 ; 1535-3877 |
ISSN | 0951-7375 ; 1355-834X |
DOI | 10.1097/QCO.0000000000001005 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 2462: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.